Table 3.

Health and economic outcomes among 20 cohorts vaccinated over 2011–2030 (2017 US$)

	No vaccine	With vaccine	Averted
Total cases	573 685	456 962	116 724
Total non-severe pneumonia cases	211 532	200 955	10 577
Total severe pneumonia cases	347 831	253 917	93 914
Total pneumococcal meningitis cases	1189	59	1129
Total pneumococcal meningitis sequelae	654	33	621
Total pneumococcal sepsis cases	12 480	1997	10 483
Total outpatient visits	159 303	150 479	8554
Total hospitalisations	297 927	210 138	87 789
Total pneumonia hospitalisations	285 222	208 212	77 010
Total pneumococcal meningitis hospitalisations	975	49	926
Total pneumococcal sepsis hospitalisations	11 730	1877	9854
Total deaths	13 633	9186	3336
Total pneumonia deaths	12 355	9019	3336
Total pneumococcal meningitis deaths	338	17	321
Total pneumococcal sepsis deaths	940	150	790
DALYs (discounted)	290 587	194 837	95 750
Total government healthcare costs
(discounted)	$13 696 698	$9 739 493	$3 957 205
Total outpatient visit costs	$801 121	$761 065	$40 056
Total hospitalisation costs	$12 895 577	$8 978 428	$3 917 149
Total societal healthcare costs
(discounted)	$24 068 433	$16 804 536	$7 263 897
Total outpatient visit costs	$2 234 169	$15 727 762	$661 407
Total hospitalisation costs	$21 834 264	$15 231 774	$6 602 490

DALY, disability-adjusted-life-year.